Therakles Pharmaceuticals AG

History from 25 Jul 2024

Nominal capital · CHFCHF 105k

SHAB published 30 Jul 2024 · legal date 25 Jul 2024
Company formed
Founded 25 Jul 2024
SHAB HR01-1006096874 ↗
SHAB published 18 May 2026 · legal date 14 Aug 2025
Capital increase
Likely financing
Paid in cash
Nominal capital
100’000 → 105’186.05
Shares
10’000 → 10’518’605
New shares, % of post-step shares
— (nominal value per share changed)
Aktienkapital neu: CHF 105'186.05 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 55'186.05 [bisher: CHF 50'000.00]. Aktien neu: 10'518'605 vinkulierte Namenaktien zu CHF 0.01 [bisher: 10'000 vinkulierte Namenaktien zu CHF 10.00]. Ordentliche Kapitalerhöhung.
From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
- The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
- The company was founded less than six years before this capital increase.+0.5
- The company's purpose describes technology or life-sciences development.+0.5
Classifier score 0.75 · likely-financing threshold 0.60 · not a calibrated probability
SHAB HR02-1006652571 ↗

Published by 24 May 2026

Record